NID2
From Wikipedia, the free encyclopedia
|
Nidogen 2 (osteonidogen)
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | NID2; | |||||||||||||
| External IDs | OMIM: 605399 MGI: 1298229 HomoloGene: 40575 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 22795 | 18074 | ||||||||||||
| Ensembl | ENSG00000087303 | ENSMUSG00000021806 | ||||||||||||
| Uniprot | Q14112 | Q3TPN0 | ||||||||||||
| Refseq | NM_007361 (mRNA) NP_031387 (protein) |
NM_008695 (mRNA) NP_032721 (protein) |
||||||||||||
| Location | Chr 14: 51.54 - 51.61 Mb | Chr 14: 18.54 - 18.6 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Nidogen 2 (osteonidogen), also known as NID2, is a human gene.[1]
Basement membranes, which are composed of type IV collagens (see MIM 120130), laminins (see LAMC1; MIM 150290), perlecan (HSPG2; MIM 142461), and nidogen (see NID1; MIM 131390), are thin pericellular protein matrices that control a large number of cellular activities, including adhesion, migration, differentiation, gene expression, and apoptosis.[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Ulazzi L, Sabbioni S, Miotto E, et al. (2007). "Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.". Mol. Cancer 6: 17. doi:. PMID 17328794.
- Nischt R, Schmidt C, Mirancea N, et al. (2007). "Lack of nidogen-1 and -2 prevents basement membrane assembly in skin-organotypic coculture.". J. Invest. Dermatol. 127 (3): 545-54. doi:. PMID 17008882.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55-65. doi:. PMID 16344560.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173-8. doi:. PMID 16189514.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Miosge N, Sasaki T, Timpl R (2003). "Evidence of nidogen-2 compensation for nidogen-1 deficiency in transgenic mice.". Matrix Biol. 21 (7): 611-21. PMID 12475645.
- Miosge N, Holzhausen S, Zelent C, et al. (2002). "Nidogen-1 and nidogen-2 are found in basement membranes during human embryonic development.". Histochem. J. 33 (9-10): 523-30. PMID 12005023.
- Tu H, Sasaki T, Snellman A, et al. (2002). "The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.". J. Biol. Chem. 277 (25): 23092-9. doi:. PMID 11956183.
- Sasaki T, Göhring W, Mann K, et al. (2002). "Short arm region of laminin-5 gamma2 chain: structure, mechanism of processing and binding to heparin and proteins.". J. Mol. Biol. 314 (4): 751-63. doi:. PMID 11733994.
- Sasaki T, Göhring W, Miosge N, et al. (1999). "Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins.". FEBS Lett. 460 (2): 280-4. PMID 10544250.
- Kohfeldt E, Sasaki T, Göhring W, Timpl R (1998). "Nidogen-2: a new basement membrane protein with diverse binding properties.". J. Mol. Biol. 282 (1): 99-109. doi:. PMID 9733643.
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791-806. PMID 8889548.

